How HCP education can drive your Medical Affairs strategy

By |2023-11-03T15:21:08+00:00February 23rd, 2023|Life Sciences|

How HCP education can drive your Medical Affairs strategy Medical Affairs (MA) teams within life sciences organizations are responsible for communicating scientific and clinical information to relevant stakeholders, including HCPs, patients, and internal stakeholders such as Medical Science Liaisons (MSLs). Most roles that MA teams now occupy were previously filled by the commercial side

Podcast launch: The Intuition Finance Digest

By |2023-02-23T14:29:55+00:00February 23rd, 2023|Finance|

Podcast launch: The Intuition Finance Digest Intuition are delighted to announce the launch of our dedicated finance podcast, The Intuition Finance Digest, offering listeners an expert take on some of the finance industry’s major trends. Intuition’s team of in-house experts are constantly monitoring developments in the finance industry to make our bespoke and off-the-shelf products

The benefits of an industry-wide perspective on asset finance

By |2023-02-22T14:32:54+00:00February 21st, 2023|Finance|

The benefits of an industry-wide perspective on asset finance In the last quarter of 2022, Intuition was privileged to deliver a new asset finance training program for a leading firm. This article highlights three reasons why this new form of training can be so impactful. 1 Representing around 3.5% of total debt finance to

Medical affairs transformation – The power of technology

By |2025-02-28T15:47:00+00:00February 16th, 2023|Life Sciences|

Medical affairs transformation - The power of technology The past three years have reshaped perspectives on the pharmaceutical industry and the real-time adaptability that underpins its clinical processes. Testament to the durability of the scientific method, the efforts of private interest, and a handful of key pharmaceutical stakeholders, the industry has paved the way in

Ratings divergence complicates anti-greenwashing measures

By |2024-04-25T14:48:11+00:00February 16th, 2023|Finance|

Ratings divergence complicates anti-greenwashing measures The risks associated with greenwashing – false/misleading marketing regarding the sustainability attributes of a product or service – are on the rise with signs that net-zero and other commitments made by some members of the financial sector may not be credible. But identification of greenwashing practices remains problematic as

Navigating today’s business challenges: The importance of L&D in 2023

By |2024-02-12T11:31:21+00:00February 10th, 2023|Corporate Learning|

Navigating today’s business challenges: The importance of L&D in 2024 In the face of ongoing business transformation and upcoming challenges in 2024, learning and development (L&D) efforts have become critical for organizational success. Some of the key business challenges identified for 2024 include current economic instability, technological advances, talent shortages, climate change, and data security

Learning & development: Key Stats in 2023

By |2024-02-12T11:32:03+00:00February 10th, 2023|Corporate Learning|

Learning & development: Key Stats in 2024 Learning and development (L&D) strategies play a significant role in any company’s growth. The main aim of these strategies is to help employees within the business build upon their skills. The correct and appropriate adoption of such initiatives should see employees’ goals and performance mirror those of

What is MiFID II/MiFIR?

By |2023-02-10T10:35:43+00:00February 9th, 2023|Finance|

What is MiFID II/MiFIR? The Markets in Financial Instruments Directive II (MiFID II) is a European Union (EU) regulation that aims to improve the transparency, fairness, and efficiency of financial markets by enhancing investor protection and promoting competition among financial firms. Introduced in January 2018, it is intended as a revision to the original MiFID, which

The key requirements of MiFID II/MiFIR

By |2023-02-10T10:37:32+00:00February 9th, 2023|Finance|

The key requirements of MiFID II/MiFIR The introduction of the MiFID II regime was not intended as a cosmetic fix to the European financial markets regulatory environment. Rather, it marked the arrival of a whole new trading and investor protection landscape whose impact will be felt globally as well as within Europe due to the many cross-border

Five human skills needed in Medical Affairs

By |2023-02-08T14:52:11+00:00February 3rd, 2023|Life Sciences|

Five human skills needed in Medical Affairs“The value of the Medical Affairs function is dependent on understanding customers’ needs and providing the right knowledge at the right time to physicians”Medical Affairs is quickly becoming one of the most strategically important functions across life sciences companies, and the remit of Medical Affairs professionals is expanding significantly.

Go to Top